Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Carbetocina para la prevención de la hemorragia posparto

Información

DOI:
https://doi.org/10.1002/14651858.CD005457.pub4Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 18 abril 2012see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Embarazo y parto

Copyright:
  1. Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Lin‐Lin Su

    Correspondencia a: Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

    [email protected]

  • Yap‐Seng Chong

    Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

  • Miny Samuel

    Research Triangle Institute‐Health Solutions, Manchester, UK

Contributions of authors

Su LL ‐ undertook searches, extracted and analysed the data, and wrote the review.

Chong YS ‐ performed data analysis and advised on the review.

Samuel M ‐ undertook searches, extracted data and performed analysis.

Sources of support

Internal sources

  • National University Hospital, Singapore.

  • Clinical Trials and Epidemiology Research Unit, Singapore.

External sources

  • No sources of support supplied

Declarations of interest

For the Su 2009 trial conducted by Su LL and Chong YS, the carbetocin was purchased from Ferring Inc at a discounted price. All decisions relating to the inclusion of the trial in this review, assessment of risk of bias and data extraction were carried out by the other review author (Miny Samuel) who was not directly involved in the trial.

Acknowledgements

We would like to acknowledge the assistance and comments provided by members of the Cochrane Pregnancy and Childbirth Group; and Edwin SY Chan's assistance with the preparation of the protocol for the review. We would also like to acknowledge the information provided to us by Professor Jerome Dansereau on his trial.

We would also like to acknowledge the assistance provided by Ms Lindsay Irish for her translation of Triopon 2010.

As part of the pre‐publication editorial process, this review has been commented on by three peers (an editor and two referees who are external to the editorial team) and the Group's Statistical Adviser.

Version history

Published

Title

Stage

Authors

Version

2012 Apr 18

Carbetocin for preventing postpartum haemorrhage

Review

Lin‐Lin Su, Yap‐Seng Chong, Miny Samuel

https://doi.org/10.1002/14651858.CD005457.pub4

2012 Feb 15

Carbetocin for preventing postpartum haemorrhage

Review

Lin‐Lin Su, Yap‐Seng Chong, Miny Samuel

https://doi.org/10.1002/14651858.CD005457.pub3

2007 Jul 18

Oxytocin agonists for preventing postpartum haemorrhage

Review

Lin‐Lin Su, Yap‐Seng Chong, Miny Samuel

https://doi.org/10.1002/14651858.CD005457.pub2

2005 Jul 20

Oxytocin agonists for preventing postpartum haemorrhage

Protocol

Lin Lin Su, Yap‐Seng Chong, E SY Chan, Miny Samuel

https://doi.org/10.1002/14651858.CD005457

Differences between protocol and review

To avoid duplication of data and consistency in reviews, the Pregnancy and Childbirth Group developed a hierarchy of reviews on prevention of postpartum haemorrhage for women giving birth vaginally as well as a set of core outcomes. The hierarchy and core outcomes were derived through consensus between the Editors and review authors and have been incorporated into this review.

We have added an additional outcome (need for uterine massage) which was not prespecified in our published protocol.

We have changed the title of this update because our search strategy did not identify trials of oxytocin agonists apart from carbetocin.

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.